Immunohistochemical expression of latent membrane protein 1 (LMP1) and p53 in nasopharyngeal carcinoma: Moroccan experience

被引:4
作者
Tabyaoui, I [1 ]
Serhier, Z. [2 ]
Sahraoui, S. [3 ]
Sayd, S. [1 ]
Cadi, R. [4 ]
Bennani, O. M. [2 ]
Benider, A. [3 ]
Zamiati, S. [5 ]
Jouti, Tahiri N. [1 ]
机构
[1] Fac Med & Pharm Casablanca, Pathol Lab, Casablanca, Morocco
[2] Fac Med & Pharm Casablanca, Med Informat Lab, Casablanca, Morocco
[3] Ibn Rochd Univ, Med Ctr, Dept Radiotherapy & Oncol, Casablanca, Morocco
[4] Fac Sci Ain Chock, Physiol & Mol Genet Lab, Casablanca, Morocco
[5] Ibn Rochd Univ, Med Ctr, Dept Pathol, Casablanca, Morocco
关键词
Epidemiology; Epstein-Barr virus; Immunohistochemistry; LMP1; Moroccan; Nasopharyngeal carcinoma; p53; Risk factors; EPSTEIN-BARR-VIRUS; EPIDEMIOLOGY; ACCUMULATION; INFECTION; OVEREXPRESSION; SELECTION; VARIANTS; BCL-2; RISK; AGE;
D O I
10.4314/ahs.v13i3.27
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor intimately associated with Epstein-Barr virus (EBV). NPC is a characteristic tumor displaying epidemiological, genetic and regional distribution properties that makes it unique by its natural behavior. Objectives: To assess the expression pattern of LMP1 and p53 proteins in the different histological types of NPC in a sample of the Moroccan population and to define any association between the expression of those proteins with the sex, the age and the histological types of NPC. Methods: Archival formalin-fixed, paraffin-embedded NPC biopsies were evaluated in 23 Moroccan patients for the presence of LMP1 and p53 using immunohistochemistry (IHC). Results: No LMP1 expression was observed whereas 8 of 23 cases (34. 7%) had detectable p53 protein in the nuclei of tumor cells. After statistical analysis according to the Fisher's exact probability test, no significant association between p53 expression and histological type, age and sex distributions was demonstrated (p>0.05). Conclusion: This study confirms that p53 overexpression is present in a subset of Moroccan NPC patients. Our results are consistent with those reported by other studies concerning the same NPC endemic risk area and provide original data concerning Morocco.
引用
收藏
页码:710 / 717
页数:8
相关论文
共 49 条
[1]  
Agaoglu FY, 2004, IN VIVO, V18, P555
[2]  
Ammor S, 2005, B MEMOIRES SOC ANTHR, V17
[3]  
[Anonymous], 2007, REG CANC REG GRAND C
[4]  
Arfaoui A., 2007, ANTROPO, V14, P75
[5]  
Bernardini S, 2001, PROG UROL, V11, P201
[6]  
Bonsing BA, 1997, CYTOMETRY, V28, P11, DOI 10.1002/(SICI)1097-0320(19970501)28:1<11::AID-CYTO2>3.3.CO
[7]  
2-H
[8]   Nasopharyngeal carcinoma [J].
Brennan, Bernadette .
ORPHANET JOURNAL OF RARE DISEASES, 2006, 1 (1)
[9]   Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy [J].
Busson, P ;
Ooka, T ;
Corbex, M .
M S-MEDECINE SCIENCES, 2004, 20 (04) :453-457
[10]   The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth [J].
Cadwell, C ;
Zambetti, GP .
GENE, 2001, 277 (1-2) :15-30